FIRAPY Presented at Thai Vascular Surgery Forum 2025

March 21, 2025

On March 4-6, 2025, our Thailand distributor K2 Medical represented FIRAPY at the event “Practical Approaches in Vascular Surgery for General Surgeons,” organized by the Thai Vascular Association in Bangkok, Thailand.


FIRAPY was showcased at Booth No. 24, where the K2 Blood Purification Division sales team introduced the clinical value of FIR therapy to vascular surgeons and healthcare professionals.


Notably, the K2 sales team is composed of
experienced dialysis nurses and medical engineers, enabling them to deliver both clinical and technical perspectives on FIRAPY’s use in vascular care.


The exhibition focused on how FIRAPY promotes vascular access function and maturation, drawing strong interest from attendees and generating meaningful discussions.


One highlight of the day was a visit from a vascular surgeon who expressed interest in FIRAPY’s potential in treating arterial insufficiency—a promising signal of future applications beyond dialysis.


We sincerely thank the K2 team for their continued dedication in expanding FIRAPY’s clinical reach across the vascular community in Thailand.

Want to know more?



Contact us for more detail


Learn more
Questions to FIRAPY
July 16, 2025
FIRAPY Medical Japan proudly participated in the 70th Annual Meeting of the Japanese Society for Dialysis Therapy (JSDT) , held in Osaka from June 27 to 29, 2025 . This year marked a major milestone for FIRAPY in Japan: a total of 11 FIRAPY-related research presentations were featured during the congress—showcasing growing academic interest in far-infrared therapy as a supportive, non-invasive treatment in dialysis care. represents a significant milestone in FIRAPY’s ongoing academic engagement in dialysis-related research.
FIRAPY collaborates with Taipei Veterans General Hospital in research on non-invasive therapies for
July 2, 2025
FIRAPY and Taipei Veterans General Hospital co-published a study in JFMA showing improved cardiovascular and infection outcomes in peritoneal dialysis patients using far-infrared therapy.
More Posts